Le Lézard
Classified in: Health, Business
Subjects: LIC, PET, ANW

PetPace to Partner with Veterinary Health Research Centers to Pioneer Canine Alzheimer's Research Using Advanced Smart Collars


PetPace, a leader in pet health monitoring technology, is excited to announce a groundbreaking collaboration with the Veterinary Health Research Centers (VHRC) to spearhead research on Canine Alzheimer's Disease. This initiative, named the Dogs Overcoming Geriatric Memory and Aging (DOGMA) Study, will leverage PetPace's cutting-edge biometric collars to monitor and analyze the health and behavior of aging dogs, shedding light on the parallels between Canine Cognitive Decline (CCD) and Alzheimer's Disease (AD) in humans.

BURLINGTON, Mass., Nov. 22, 2023 /PRNewswire-PRWeb/ -- PetPace, a leader in pet health monitoring technology, is excited to announce a groundbreaking collaboration with the Veterinary Health Research Centers (VHRC) to spearhead research on Canine Alzheimer's Disease. This initiative, named the Dogs Overcoming Geriatric Memory and Aging (DOGMA) Study, will leverage PetPace's cutting-edge biometric collars to monitor and analyze the health and behavior of aging dogs, shedding light on the parallels between Canine Cognitive Decline (CCD) and Alzheimer's Disease (AD) in humans.

PetPace CEO, Lior Abraham, stated, "At PetPace, we are committed to advancing the well-being of pets through innovative technology. Partnering with esteemed researchers to explore Canine Alzheimer's Disease aligns perfectly with our mission."

PetPace is widely regarded as the most advanced AI smart collar for continuously monitoring the health and well-being of dogs, in addition to offering GPS location tracking solutions. While some collars track activity or other surface-level measurements, only PetPace's patented smart collar uses sophisticated artificial intelligence and machine learning powered by millions of data points across all major vital signs and biometrics to provide the most comprehensive analysis of a dog's health. PetPace is used and sold for pet owners who care about their dog's well-being as well as veterinarians and research institutes worldwide. The PetPace smart collar is well known for its ability to continuously measure an array of vital signs, collecting invaluable data for pet owners and professional medical researchers alike.

The study, led by Dr. Joel Ehrenzweig, DVM, and Dr. Robert P. Hunter, PhD, aims to address the critical need for translational research models for Alzheimer's Disease, a prevalent condition in both humans and aging dogs. Recent research has identified striking similarities between CCD and AD, including neurodegeneration, behavioral changes, and shared clinical features.

PetPace's smart collar, equipped with advanced sensors and powered by artificial intelligence machine learning technology, will play a pivotal role in the DOGMA Study by continuously monitoring key physiological parameters such as heart rate, respiratory rate, temperature, and activity levels in mature and older dogs. This continuous collection of data will provide invaluable insights into the progression of CCD and its potential links to AD.

Dr. Asaf Dagan, PetPace's Chief Veterinarian, highlighted the importance of this collaboration, stating, "The PetPace smart collar is a game-changer in our research efforts. By continuously monitoring vital signs and behaviors, we can gather a wealth of information surrounding cognitive changes in dogs over time. This is a crucial step toward enhancing our understanding of Canine Alzheimer's Disease and exploring potential interventions to improve the quality of life for our canine companions."

PetPace CEO, Lior Abraham, expressed enthusiasm for the partnership, stating, "At PetPace, we are committed to advancing the well-being of pets through innovative technology. Partnering with esteemed researchers to explore Canine Alzheimer's Disease aligns perfectly with our mission. The data collected through our smart collar will not only contribute to scientific knowledge but also open new possibilities for proactive life-saving healthcare in the canine community."

About PetPace

Our mission is to help pets live a good, long, and healthy life. PetPace is composed of veterinarians, IoT professionals, engineers, algorithms experts, data specialists, and pet owners who founded the company in 2012. We continue to perform thorough research with top universities and research institutes worldwide to constantly improve our wearable technology abilities ? to continue protecting the lives of our pets.

About VHRC

Veterinary Health Research Centers (VHRC) specializes in clinical research that advances comparative medicine, aligning with the One Health initiative by integrating veterinary insights into broader healthcare. VHRC champions a unified approach to human and animal health, promoting thorough strategies to enhance the well-being of both. Specializing in innovative research on animals with naturally occurring diseases, VHRC delivers critical insights to various clients, from developers of advanced technologies such as PetPace collars to pharmaceutical companies requiring solid empirical data for regulatory compliance. Moreover, startups and businesses with consumer health products collaborate with VHRC to affirm the efficacy of their goods.

Media Contact

Ross Bialowas, PetPace, 978-785-7223, [email protected], https://petpace.com/

SOURCE PetPace


These press releases may also interest you

at 18:37
Pomerantz LLP is investigating claims on behalf of investors of Hertz Global Holdings, Inc. ("Hertz" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 18:37
Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980...

at 18:37
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 18:36
MCAN Mortgage Corporation d/b/a MCAN Financial Group ("MCAN", the "Company" or "we") reported net income of $23.2 million ($0.65 earnings per share) for the first quarter of 2024, relatively consistent with net income of $23.3 million ($0.67...

at 18:35
Ascot Resources Ltd. ("Ascot" or the "Company") today announces that effective May 9, 2024, Don Njegovan is stepping down as a Director of the Company to focus on his duties at Osisko Mining Inc. Ascot's remaining six Directors have appointed Derek...

at 18:24
Itaú Unibanco Holding S.A. announces to its shareholders and the market at large that the Complete Financial Statements and the Management Discussion and Analysis for the 1st quarter of 2024 ending March 31, 2024, are already available on the...



News published on and distributed by: